|
FDA Announcement - Small Molecule Nitrosamines in Infusion Bags
|
|
17
|
2742
|
March 31, 2026
|
|
N-nitroso-Furosemide
|
|
2
|
490
|
March 31, 2026
|
|
Analysis method of cream
|
|
6
|
261
|
March 30, 2026
|
|
Determination of N-nitroso Caspofungin
|
|
1
|
112
|
March 27, 2026
|
|
Excipient Nitrosamine Risk Assessment Tool
|
|
1
|
510
|
March 26, 2026
|
|
Nitrosamine formation in differnt dosage forms
|
|
10
|
398
|
March 24, 2026
|
|
Optimized UHPLC–Derivatization Method for Low-Level Nitrite Detection in Pharmaceutical Excipients-Pub
|
|
0
|
202
|
March 23, 2026
|
|
Impact of post approval quantitative changes in excipient composition on nitrosamine formation: De-risking strategy-Pub
|
|
0
|
128
|
March 23, 2026
|
|
👨💻 Determination of nitrite and nitrate in Microcrystalline Cellulose by ion chromatography
|
|
0
|
190
|
March 23, 2026
|
|
How to Validate High-Resolution Mass Spectrometry for Nitrosamine Detection in Pharmaceuticals
|
|
3
|
357
|
March 21, 2026
|
|
N-Nitrosoatorvastatin and applicable potency category 4 or 5
|
|
2
|
120
|
March 20, 2026
|
|
Mutagenicity of EAT-positive NDSRIs in HepaRG spheroids-Pub
|
|
0
|
70
|
March 20, 2026
|
|
Minimizing in Source Fragmentation for Mass Spectrometry Based NDSRI Analytical Procedures: A Case Study of Nitroso-bumetanide -Pub
|
|
4
|
314
|
March 19, 2026
|
|
Request for analytical method support – N-nitroso-piperidine in LVP elastomeric packaging (E&L study)
|
|
0
|
125
|
March 19, 2026
|
|
Physical form of nitrosamine Standards
|
|
1
|
128
|
March 18, 2026
|
|
Differences in Physical Form of Nitrosamine Reference Standards: USP vs. Other Suppliers
|
|
2
|
159
|
March 18, 2026
|
|
Scientific Clarification Request on Analytical Approach for Nitrosamine Determination in Quetiapine Oral Suspension
|
|
3
|
235
|
March 17, 2026
|
|
Research on Nitrosamines in Complex Preparations
|
|
2
|
190
|
March 17, 2026
|
|
MEGLUMINE (Methylglucamine)
|
|
28
|
3763
|
March 16, 2026
|
|
EMA Q&A Appendix 1 update posted on 13 March 2026
|
|
1
|
444
|
March 16, 2026
|
|
Challenges in developing an analytical method for N‑nitroso‑ambroxol -
|
|
1
|
147
|
March 14, 2026
|
|
Testing of N-nitroso-cinacalcet
|
|
8
|
1035
|
March 14, 2026
|
|
Limit Test for NDSRI Risk Assessment?
|
|
3
|
187
|
March 13, 2026
|
|
Navigating the complexities in characterization of NDSRIs using advanced analytical techniques-Pub
|
|
2
|
239
|
March 12, 2026
|
|
Challenges in developing an analytical method for N‑nitroso‑ambroxol
|
|
3
|
217
|
March 11, 2026
|
|
Register for Free Webinar- Australia and New Zealand: Nitrosamines Impurities 19 March 2026
|
|
0
|
217
|
March 10, 2026
|
|
Register for Quality Hour- Japan Edition: Nitrosamines Impurities 18 March 2026
|
|
0
|
221
|
March 8, 2026
|
|
N-nitroso-Duloxetine recall back in the news!
|
|
21
|
4766
|
March 7, 2026
|
|
Nitrosamine analysis in suspension dosage forms
|
|
5
|
273
|
March 6, 2026
|
|
Nitrosamine Risk in Trospium chloride tablets
|
|
2
|
156
|
March 4, 2026
|